重要臓器支援システム・メディカルバイオニクスの世界市場:製品別(重要臓器支援システム、メディカルバイオニクス)、エンドユーザー別(病院、外来手術センター、その他)...市場調査レポートについてご紹介

【英文タイトル】Vital Organs Support Systems and Medical Bionics Market by Product (Vital organs support systems and Medical Bionics) and End User (Hospitals, Ambulatory Surgical Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2018–2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective
2.2. Key findings

2.2.1. Top impacting factors
2.2.2. Top investment pockets

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key Forces Shaping vital organs support systems and medical bionics Market

3.2.1. Moderate bargaining power of suppliers
3.2.2. Low threat of new entrants
3.2.3. Low threat of substitutes
3.2.4. Moderate intensity of rivalry
3.2.5. High bargaining power of buyers

3.3. Pricing Analysis

3.3.1. Pricing Analysis, By Region, 2018 & 2025

3.4. Value Chain Analysis
3.5. Impact of government regulations on global vital organs support systems and medical bionics market
3.6. Clinical Trials
3.7. Industry Pain point analysis
3.8. Case Studies

3.8.1. Case Study 01

3.9. Market dynamics

3.9.1. Drivers

3.9.1.1. Increase in incidence of cardiac disorders and growth in geriatric population
3.9.1.2. Rise in number of patients suffering from chronic diseases
3.9.1.3. Technological advancements

3.9.2. Restraints

3.9.2.1. High cost of treatment
3.9.2.2. Stringent approval process

3.9.3. Opportunities

3.9.3.1. Lucrative opportunities in emerging economies

CHAPTER 4: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE

4.1. Overview
4.2. Market size and forecast
4.3. Vital organs support systems

4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by type

4.3.2.1. Artificial Heart

4.3.2.1.1. Market size and forecast

4.3.2.2. Artificial Kidney

4.3.2.2.1. Market size and forecast

4.3.2.3. Artificial Pancreas

4.3.2.3.1. Market size and forecast

4.3.2.4. Artificial Urinary Bladder

4.3.2.4.1. Market size and forecast

4.3.2.5. Artificial Lungs

4.3.2.5.1. Market size and forecast

4.3.2.6. Artificial Liver

4.3.2.6.1. Market size and forecast

4.3.3. Market size and forecast, by region
4.3.4. Market analysis by country

4.4. Medical Bionics

4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by type

4.4.2.1. Bionic Eye

4.4.2.1.1. Market size and forecast

4.4.2.2. Ear Bionics

4.4.2.2.1. Market size and forecast, by type

4.4.2.2.1.1.1. Cochlear Implants

4.4.2.2.1.1.1.1 Market size and forecast

4.4.2.2.1.1.2. Bone Anchored Hearing Systems

4.4.2.2.1.1.2.1. Market size and forecast

4.4.2.2.1.1.3. Auditory Brainstem Implants

4.4.2.2.1.1.3.1 Market size and forecast

4.4.2.3. Orthopedic Bionics

4.4.2.3.1. Market size and forecast, by type

4.4.2.3.1.1.1. Upper Limb
4.4.2.3.1.1.2. Market size and forecast
4.4.2.3.1.1.3. Lower Limb
4.4.2.3.1.1.4. Market size and forecast, by type

4.4.2.3.1.1.4.1. Bionic Knee

4.4.2.3.1.1.4.1.1. Market size and forecast

4.4.2.3.1.1.4.2. Bionic Feet

4.4.2.3.1.1.4.2.1. Market size and forecast

4.4.2.3.1.1.5. Exoskeleton
4.4.2.3.1.1.6. Market size and forecast
4.4.2.3.1.1.7. Electrical Bone Growth Stimulators
4.4.2.3.1.1.8. Market size and forecast, by type

4.4.2.3.1.1.8.1. Invasive Bone Growth Stimulators

4.4.2.3.1.1.8.1.1. Market size and forecast

4.4.2.3.1.1.8.2. Non-Invasive Bone Growth Stimulators

4.4.2.3.1.1.8.2.1. Market size and forecast

4.4.2.4. Cardiac Bionics

4.4.2.4.1. Market size and forecast, by type

4.4.2.4.1.1.1. Pacemaker

4.4.2.4.1.1.1.1 Market size and forecast, by type

4.4.2.4.1.1.2. Implantable Pacemaker

4.4.2.4.1.1.2.1. Market size and forecast

4.4.2.4.1.1.3. External pacemaker

4.4.2.4.1.1.3.1 Market size and forecast

4.4.2.4.1.1.3. Ventricular Assist Devices (VADs)

4.4.2.4.1.1.4. Market size and forecast, by type

4.4.2.4.1.1.4.1. Left Ventricular Assist Device (LVAD)

4.4.2.4.1.1.4.1.1. Market size and forecast

4.4.2.4.1.1.4.2. Right Ventricular Assist Device (RVAD)

4.4.2.4.1.1.4.2.1. Market size and forecast

4.4.2.4.1.1.4.3. Biventricular Assist Device (BIVAD)

4.4.2.4.1.1.4.3.1. Market size and forecast

4.4.2.4.1.1.5. Artificial Heart Valves
4.4.2.4.1.1.6. Market size and forecast, by type

4.4.2.4.1.1.6.1. Mechanical Heart Valves

4.4.2.4.1.1.6.1.1. Market size and forecast

4.4.2.4.1.1.6.2. Tissue Heart Valves

4.4.2.4.1.1.6.2.1. Market size and forecast

4.4.2.5. Neural Bionics

4.4.2.5.1. Market size and forecast, by type

4.4.2.5.1.1. Internal Neurostimulators

4.4.2.5.1.1.1. Market size and forecast, by type

4.4.2.5.1.1.1.1. Deep Brain Stimulators (DBS)

4.4.2.5.1.1.1.1.1. Market size and forecast

4.4.2.5.1.1.1.2. Sacral Nerve Stimulators (SNS)

4.4.2.5.1.1.1.2.1. Market size and forecast

4.4.2.5.1.1.1.3. Vagus Nerve Stimulators (VNS)

4.4.2.5.1.1.1.3.1. Market size and forecast

4.4.2.5.1.1.1.4. Spinal Cord Stimulators (SCS)

4.4.2.5.1.1.1.4.1. Market size and forecast

4.4.2.5.1.1.1.5. Other Neurostimulators

4.4.2.5.1.1.1.5.1. Market size and forecast

4.4.2.5.1.2. External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))

4.4.2.5.1.2.1. Market size and forecast

4.4.3. Market size and forecast, by region
4.4.4. Market analysis by country

CHAPTER 5: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER

5.1. Overview
5.2. Market size and forecast
5.3. Hospitals

5.3.1. Market size and forecast, by region
5.3.2. Market analysis by country

5.4. Ambulatory surgical centers (ASCs)

5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country

5.5. Others

5.5.1. Market size and forecast, by region
5.5.2. Market analysis by country

CHAPTER 6: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends and opportunities
6.2.2. North America vital organs support systems and medical bionics market, by country

6.2.2.1. U.S. vital organs support systems and medical bionics market, by product type
6.2.2.2. U.S. vital organs support systems and medical bionics market, by end user
6.2.2.3. Canada vital organs support systems and medical bionics market, by product type
6.2.2.4. Canada vital organs support systems and medical bionics market, by end user
6.2.2.5. Mexico vital organs support systems and medical bionics market, by product type
6.2.2.6. Mexico vital organs support systems and medical bionics market, by end user

6.2.3. North America vital organs support systems and medical bionics market, by product type
6.2.5. North America vital organs support systems and medical bionics market, by end user

6.3. Europe

6.3.1. Key market trends and opportunities
6.3.2. Europe vital organs support systems and medical bionics market, by country

6.3.2.1. Germany vital organs support systems and medical bionics market, by product type
6.3.2.3. Germany vital organs support systems and medical bionics market, by end user
6.3.2.4. France vital organs support systems and medical bionics market, by product type
6.3.2.6. France vital organs support systems and medical bionics market, by end user
6.3.2.7. Spain vital organs support systems and medical bionics market, by product type
6.3.2.8. Spain vital organs support systems and medical bionics market, by end user
6.3.2.9. Italy vital organs support systems and medical bionics market, by product type
6.3.2.11. Italy vital organs support systems and medical bionics market, by end user
6.3.2.12. UK vital organs support systems and medical bionics market, by product type
6.3.2.13. UK vital organs support systems and medical bionics market, by end user
6.3.2.14. Rest of Europe vital organs support systems and medical bionics market, by product type
6.3.2.15. Rest of Europe vital organs support systems and medical bionics market, by end user

6.3.3. Europe vital organs support systems and medical bionics market, by product type
6.3.5. Europe vital organs support systems and medical bionics market, by end user

6.4. Asia-Pacific

6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific vital organs support systems and medical bionics market, by country

6.4.2.1. Australia vital organs support systems and medical bionics market, by product type
6.4.2.2. Australia vital organs support systems and medical bionics market, by end user
6.4.2.3. Japan vital organs support systems and medical bionics market, by product type
6.4.2.4. Japan vital organs support systems and medical bionics market, by end user
6.4.2.5. India vital organs support systems and medical bionics market, by product type
6.4.2.6. India vital organs support systems and medical bionics market, by end user
6.4.2.7. China vital organs support systems and medical bionics market, by product type
6.4.2.8. China vital organs support systems and medical bionics market, by end user
6.4.2.9. South Korea vital organs support systems and medical bionics market, by product type
6.4.2.10. South Korea vital organs support systems and medical bionics market, by end user
6.4.2.11. Rest of Asia-Pacific vital organs support systems and medical bionics market, by product type
6.4.2.12. Rest of Asia-Pacific vital organs support systems and medical bionics market, by end user

6.4.3. Asia-Pacific vital organs support systems and medical bionics market, by product type
6.4.5. Asia-Pacific vital organs support systems and medical bionics market, by end user

6.5. LAMEA

6.5.1. Key market trends and opportunities
6.5.2. LAMEA vital organs support systems and medical bionics market, by country

6.5.2.1. Brazil vital organs support systems and medical bionics market, by product type
6.5.2.2. Brazil vital organs support systems and medical bionics market, by end user
6.5.2.3. Saudi Arabia vital organs support systems and medical bionics market, by product type
6.5.2.4. Saudi Arabia vital organs support systems and medical bionics market, by end user
6.5.2.5. South Africa vital organs support systems and medical bionics market, by product type
6.5.2.6. South Africa vital organs support systems and medical bionics market, by end user
6.5.2.7. Rest of LAMEA vital organs support systems and medical bionics market, by product type
6.5.2.8. Rest of LAMEA vital organs support systems and medical bionics market, by end user

6.5.3. LAMEA vital organs support systems and medical bionics market, by product type
6.5.5. LAMEA vital organs support systems and medical bionics market, by end user

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Market Share Analysis of Top Players, 2018 (%)
7.4. Top winning strategies

7.4.1. Top Winning Strategies, By Year, 2015-2019*
7.4.2. Top Winning Strategies, By Development, 2015-2019* (%)
7.4.3. Top Winning Strategies, By Company, 2015-2019*

7.5. Product Mapping of Top 12 Player

CHAPTER 8: COMPANY PROFILES:

8.1. Abiomed, Inc.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Product portfolio
8.1.4. Business performance
8.1.5. Key strategic moves and developments

8.2. Abbott Laboratories (St. Jude Medical)

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments

8.3. Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.)

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance

8.4. Baxter International Inc.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments

8.5. Boston Scientific Corporation

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments

8.6. Cochlear Ltd.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments

8.7. Edwards Lifesciences Corporation

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments

8.8. Jarvik Heart, Inc.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments

8.9. Medtronic Plc. (Covidien Ltd.)

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments

8.10. Össur Americas, Inc.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments

8.11. Second Sight Medical Products, Inc.

8.11.1. Company overview
8.11.2. Company snapshot
8.11.3. Product portfolio
8.11.4. Key strategic moves and developments
8.12. SynCardia Systems LLC
8.12.1. Company overview
8.12.2. Company snapshot
8.12.3. Product portfolio


【レポート販売概要】

■ タイトル:重要臓器支援システム・メディカルバイオニクスの世界市場:製品別(重要臓器支援システム、メディカルバイオニクス)、エンドユーザー別(病院、外来手術センター、その他)
■ 英文:Vital Organs Support Systems and Medical Bionics Market by Product (Vital organs support systems and Medical Bionics) and End User (Hospitals, Ambulatory Surgical Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2018–2025
■ 発行日:2019年5月31日
■ 調査会社:Allied Market Research
■ 商品コード:AMR9AG039
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。